Rapport Therapeutics, Inc. logo

Rapport Therapeutics, Inc. (RAPP) Q1 2025 Earnings

RAPP·Reported May 8, 2025·Before market open

Diluted EPS came in at $-0.68, beat the $-0.77 consensus by $0.09.

Diluted EPS
$-0.68beat by $0.09
Consensus: $-0.77
SEC

SEC Filings

Earnings release8-K not filed yet
Quarterly report10-Q · 0000950170-25-066393

Financial Snapshot

Trailing eight quarters through Q1 2025

View all metrics

Revenue

View metric

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q1 2025 Earnings FAQ

Common questions about Rapport Therapeutics, Inc.'s Q1 2025 earnings report.

Rapport Therapeutics, Inc. (RAPP) reported Q1 2025 earnings on May 8, 2025 before market open.

Rapport Therapeutics, Inc. reported diluted EPS of $-0.68 for Q1 2025.

EPS beat the consensus estimate of $-0.77 by $0.09.

You can read the 10-Q periodic report (0000950170-25-066393) directly on SEC EDGAR. The filing index links above go to sec.gov.